American Society of Gene + Cell Therapy
@asgct
Advancing knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease.
Hear from leading minds in oncology at this fully virtual event! Join us Oct 14-15 to learn about the innovative approaches reshaping cancer treatment while addressing the critical challenges currently facing the field. Register now ➡️ https://bit.ly/4aX9OVW
From blood cancers to autoimmune diseases, CAR T-cell therapy is expanding far beyond its original boundaries. Start learning in our latest content collection: https://learning.asgct.org/courses/238146
A new stage for Breakthroughs: Join us in Nashville! Customize your experience across three concurrent tracks covering translation & manufacturing, biological precision, and the new therapeutic architectures overcoming challenges in the central nervous system: asgct.org/breakthroughs
Fyodor Urnov, 2026 ASGCT Catalyst Award co-recipient, joins this episode of The Issue to discuss the rapid evolution of gene-editing technology and the critical role of industry-wide collaboration in bringing life-changing therapies to patients. 🎧 Listen: https://bit.ly/4h8nDob
Level up your cell and gene therapy experience in just one day! Dive into real-world applications of AAV, CAR T, and HSC modalities, clinical management of toxicities, and the future of individualized medicine at this focused, one-day event at @nationwidekids.bsky.social! Details: asgct.org/gme
Looking for a community that supports your career and keeps you connected to the latest in the field? Join ASGCT this summer and save up to 15% on your dues! asgct.org/become-a-member
The ASGCT Policy Summit is uniquely designed to break down silos and spark real collaboration with the stakeholders driving the future of cell and gene therapy policy. Join us September 14 in Washington, D.C., or online: asgct.org/policysummit
Applications are open for the ASGCT Career Development Awards, offering vital financial support to early-career scientists and postdocs driving innovation in the field. Don't miss the chance to fund your research and grow your network. Apply today: asgct.org/cda
Biomedical innovation depends on stable research funding. We're leading a sign-on letter opposing proposed OMB changes that could slow progress in #CGTs. Organizations can sign by July 15 at 12 p.m. ET. 🔗 Sign here: https://bit.ly/4gdQ8AA
What does the path to leadership in cell and gene therapy look like? Scientists, Unedited host Eirini Vamva, PhD, sits down with ASGCT President Matthew Porteus, PhD, for a candid conversation about his journey, motivations, and life beyond the lab. 🎧 Listen: https://bit.ly/4uZYFea
In rare disease research, traditional clinical trials aren't always possible. Check out this Community Quick Take to learn how patient data is helping researchers go beyond the placebo control and accelerate life-changing treatments. ▶️ Watch now: https://bit.ly/4fLiguF
📢 Registration and abstract submissions are officially open for Breakthroughs in Cell & Gene Therapy! Explore our 2026 program tracks, view abstract categories, and secure your spot today: asgct.org/breakthroughs
From dreaming about genetics since high school in Nigeria to tackling the field's biggest immune challenges as a University of Missouri PhD candidate, Godwin Iroanya's journey is all about making the "impossible" possible. Listen now: https://bit.ly/4ewfqaB
Bringing a cell or gene therapy from concept to patient requires more than great science. The 2026 ASGCT Policy Summit dives into the full arc of CGT development, from pipeline funding and regulatory strategy through manufacturing, payment policy, and patient access. Join us:: asgct.org/policysummit
Get to know the new co-hosts, Jason West, PhD, and Sanjay D’Souza, PhD, as they share their backgrounds, ask each other questions, and share how listeners can get involved with future content of The Issue podcast. 🎧 Listen now: https://bit.ly/4vUjSXA
While AAV and LNPs continue to revolutionize the field, translating these powerful delivery platforms into safe, predictable, and scalable clinical therapies presents unique challenges. We're partnering with @childrensphila.bsky.social for this comprehensive, one-day event: https://bit.ly/4uK4PPz
How has ASGCT membership shaped a career in regulatory policy? Hear from Dylan Bechtle, Director of Regulatory Policy at Johnson & Johnson, on how the ASGCT community and resources have been invaluable for navigating the fast-moving cell and gene therapy space. 🎧 Listen now: https://bit.ly/3Q0zvxG
It's never been easier to start building your foundational knowledge of CGT! Our Foundations of Cell & Gene Therapy online course is: ✔️ 100% free ✔️ Entirely self-paced ✔️ Led by field experts Choose a module and start learning today: https://bit.ly/4tmnsIK
Designed specifically for the next generation of medical leaders, this focused, one-day program provides the critical insights needed to navigate the rapidly evolving clinical landscape of cell and gene therapies. Learn more and register: asgct.org/gme
Our premier policy event is returning to Washington, D.C.! Join us on September 14 to connect directly with key decision-makers, advocate for the field, and drive the critical conversations shaping the future of cell and gene therapy. Secure your spot today: asgct.org/policysummit
New ASGCT member Dr. Mark Deehan (Mass General Hospital) discusses how his ASGCT Career Development Award, funded by the Foundation for Angelman Syndrome Therapeutics, is fueling new progress in his lab's research. 🎧 Listen now: https://bit.ly/4nXDck9
Ready to take your research to the next level? Early-career researchers and emerging investigators are invited to apply for these $100K grant opportunities: ✔️ Career Development Award: asgct.org/cda ✔️ Expanding Pathways Fellowship: asgct.org/expanding
Patient advocate Chrissy Green (Finding Hope for Frizzle) joins host Ben McLeod to discuss her parent-led organization's mission to develop an FRRS1L treatment and how the ASGCT Annual Meeting helps bridge the gap between advocacy and scientific development. 🎧 Listen now: https://bit.ly/43t3zF1
Divergent regulatory expectations remain a major hurdle for cell and gene therapy developers and patient access worldwide. Join us for a free webinar on June 24 to hear from the ICH Cell & Gene Therapy Discussion Group: https://bit.ly/3RBl2s4
#ASGCT2026 brought together thousands of clinicians, scientists, industry leaders, and patient advocates for an incredible week of groundbreaking science and connection. Mark your calendars – we can't wait to see you all in Philadelphia for #ASGCT2027, May 3–7, 2027!
Recorded live at #ASGCT2026, host Ben McLeod catches up with Dr. Marco Carpenter of @childrensphila.bsky.social. Dr. Carpenter discusses his research journey, the evolving landscape of cell and gene therapy, and how the ASGCT community supports early-career researchers: https://bit.ly/4uXJn9V
The ASGCT office has a new home! Find us at 20700 Swenson Drive, Suite 200 in Waukesha, Wisconsin.
What a night! 🦖 We loved seeing everyone networking alongside the exhibits and celebrating an unforgettable week. It was the perfect way to wind down, toast the incredible momentum of #ASGCT2026, and wrap up our time in Boston. Thank you to everyone who came out to celebrate with us!
Wrapping up an incredible week in Boston with a look at the future of the field! Join us this afternoon for the Outstanding New Investigator Symposium honoring these incredible award winners. Session details: https://pag.virtual-meeting.org/US/asgct2026/en-US/pag/session/119407
Between the high-energy discussions in the exhibit hall and the deep dives into the latest breakthroughs, the momentum in Boston is at an all-time high. We are heading into our final day of #ASGCT2026 tomorrow, and we can't wait to close out an incredible week with all of you!